Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hogan

Showing results (1171-1180 of 1,303) with videos related to

Pageof 131
Sort By:
Bone Marrow Transplantation|May 3, 2020
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S Al Saleh, M Hasib Sidiqi, JaeWon Lee, et al.
Nature|August 28, 2015
Multi-gigaelectronvolt acceleration of positrons in a self-loaded plasma wakefieldS Corde, E Adli, J M Allen, et al.
Fetal Diagnosis and Therapy|July 8, 2020
Fetal Cardiac Intervention for Pulmonary Atresia with Intact Ventricular Septum: International Fetal Cardiac Intervention RegistryWhitnee J Hogan, Sofia Grinenco, Aimee Armstrong, et al.
Mayo Clinic Proceedings|October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiativeMorie A Gertz, Stephen M Ansell, David Dingli, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Submesoscale dispersion in the vicinity of the Deepwater Horizon spillAndrew C Poje, Tamay M Ozgökmen, Bruce L Lipphardt, et al.
American Journal of Hematology|June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaAngela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Mayo Clinic Proceedings|August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented GroupRonald S Go, Jeffrey L Winters, Nelson Leung, et al.
Clinical Medicine & Research|May 29, 2009
Perioperative genomic profiles using structure-specific oligonucleotide probesKirk J Hogan, James K Burmester, Michael D Caldwell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2015
The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantationNelson Leung, Shaji K Kumar, Siobhan V Glavey, et al.
JAMA Dermatology|April 9, 2020
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsJeffrey F Scott, Kevin R Brough, Konstantin V Grigoryan, et al.
Pageof 131

Showing results (1171-1180 of 1,303) with videos related to

Sort By:
Pageof 131
Bone Marrow Transplantation|May 3, 2020
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S Al Saleh, M Hasib Sidiqi, JaeWon Lee, et al.
Nature|August 28, 2015
Multi-gigaelectronvolt acceleration of positrons in a self-loaded plasma wakefieldS Corde, E Adli, J M Allen, et al.
Fetal Diagnosis and Therapy|July 8, 2020
Fetal Cardiac Intervention for Pulmonary Atresia with Intact Ventricular Septum: International Fetal Cardiac Intervention RegistryWhitnee J Hogan, Sofia Grinenco, Aimee Armstrong, et al.
Mayo Clinic Proceedings|October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiativeMorie A Gertz, Stephen M Ansell, David Dingli, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Submesoscale dispersion in the vicinity of the Deepwater Horizon spillAndrew C Poje, Tamay M Ozgökmen, Bruce L Lipphardt, et al.
American Journal of Hematology|June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaAngela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Mayo Clinic Proceedings|August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented GroupRonald S Go, Jeffrey L Winters, Nelson Leung, et al.
Clinical Medicine & Research|May 29, 2009
Perioperative genomic profiles using structure-specific oligonucleotide probesKirk J Hogan, James K Burmester, Michael D Caldwell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2015
The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantationNelson Leung, Shaji K Kumar, Siobhan V Glavey, et al.
JAMA Dermatology|April 9, 2020
Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsJeffrey F Scott, Kevin R Brough, Konstantin V Grigoryan, et al.
Pageof 131